nach oben

Erschienen in:

02.05.2023 | Original Article

Human TFF2-Fc fusion protein alleviates DSS-induced ulcerative colitis in C57BL/6 mice by promoting intestinal epithelial cells repair and inhibiting macrophage inflammation

verfasst von: Meng Guo, Rongrong Wang, Jiajia Geng, Zhen Li, Mingfei Liu, Xuxiu Lu, Jianteng Wei, Ming Liu

Erschienen in: Inflammopharmacology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

The clinical drugs for ulcerative colitis mainly affect the inflammatory symposiums with limited outcomes and various side effects. Repairing the damaged intestinal mucosa is a promising and alternative strategy to treat ulcerative colitis. Trefoil factor family 2 (TFF2) could repair the intestinal mucosa, however, it has a short half-life in vivo. To improve the stability of TFF2, we have prepared a new fusion protein TFF2-Fc with much stability, investigated the therapeutic effect of TFF2-Fc on ulcerative colitis, and further illustrated the related mechanisms. We found that intrarectally administered TFF2-Fc alleviated the weight loss, the colon shortening, the disease activity index, the intestinal tissue injury, and the lymphocyte infiltration in dextran sulfate sodium (DSS)-induced colitis mice. In vitro, TFF2-Fc inhibited Caco2 cells injury and apoptosis, promoted cellular migration, and increased the expression of Occludin and ZO-1 by activating P-ERK in the presence of H₂O₂ or inflammatory conditioned medium (LPS-RAW264.7/CM). Moreover, TFF2-Fc could reduce lipopolysaccharide (LPS)-induced production of inflammation cytokines and reactive oxygen species in RAW264.7 cells, and also inhibits the polarization of RAW264.7 cells to M1 phenotype by reducing glucose consumption and lactate production. Taken together, in this work, we have prepared a novel fusion protein TFF2-Fc, which could alleviate ulcerative colitis in vivo via promoting intestinal epithelial cells repair and inhibiting macrophage inflammation, and TFF2-Fc might serve as a promising ulcerative colitis therapeutic agent.

Agagunduz D, Gencer Bingol F, Celik E, Cemali O, Ozenir C, Ozogul F, Capasso R (2022a) Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions. J Transl Med 20:460. https://doi.org/10.1186/s12967-022-03609-yCrossRefPubMedPubMedCentral

Agagunduz D, Kocaadam-Bozkurt B, Bozkurt O, Sharma H et al (2022b) Microbiota alteration and modulation in Alzheimer’s disease by gerobiotics: the gut-health axis for a good mind. Biomed Pharmacother 153:113430. https://doi.org/10.1016/j.biopha.2022.113430CrossRefPubMed

Aihara E, Engevik KA, Montrose MH (2017) Trefoil factor peptides and gastrointestinal function. Annu Rev Physiol 79:357–380. https://doi.org/10.1146/annurev-physiol-021115-105447CrossRefPubMed

Arnold P, Rickert U, Helmers AK et al (2016) Trefoil factor 3 shows anti-inflammatory effects on activated microglia. Cell Tissue Res 365(1):3–11. https://doi.org/10.1007/s00441-016-2370-5CrossRefPubMed

Basuroy S, Seth A, Elias B, Naren AP, Rao R (2006) MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 393(Pt 1):69–77. https://doi.org/10.1042/BJ20050959CrossRefPubMed

Boal Carvalho P, Cotter J (2017) Mucosal healing in ulcerative colitis: a comprehensive review. Drugs 77(2):159–173. https://doi.org/10.1007/s40265-016-0676-yCrossRefPubMed

Chen L, Lv Z, Gao Z et al (2019) Human beta-defensin-3 reduces excessive autophagy in intestinal epithelial cells and in experimental necrotizing enterocolitis. Sci Rep 9(1):19890. https://doi.org/10.1038/s41598-019-56535-3CrossRefPubMedPubMedCentral

Chu Q, Yu X, Jia R et al (2019) Flavonoids from Apios americana Medikus leaves protect RAW264.7 cells against inflammation via inhibition of MAPKs, Akt-mTOR pathways, and Nfr2 activation. Oxid Med Cell Longev 2019:1563024. https://doi.org/10.1155/2019/1563024CrossRefPubMedPubMedCentral

Cui L, Guan X, Ding W et al (2021) Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. Int J Biol Macromol 166:1035–1045. https://doi.org/10.1016/j.ijbiomac.2020.10.259CrossRefPubMed

da Silva VC, de Araujo AA, de Souza Araujo DF et al (2018) Intestinal anti-inflammatory activity of the aqueous extract from Ipomoea asarifolia in DNBS-induced colitis in rats. Int J Mol Sci. https://doi.org/10.3390/ijms19124016CrossRefPubMedPubMedCentral

Dai C, Zhao DH, Jiang M (2012) VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. Int J Mol Med 29(2):202–208. https://doi.org/10.3892/ijmm.2011.839CrossRefPubMed

Engevik KA, Hanyu H, Matthis AL et al (2019) Trefoil factor 2 activation of CXCR4 requires calcium mobilization to drive epithelial repair in gastric organoids. J Physiol 597(10):2673–2690. https://doi.org/10.1113/JP277259CrossRefPubMedPubMedCentral

Feuerstein JD, Moss AC, Farraye FA (2019) Ulcerative colitis. Mayo Clin Proc 94(7):1357–1373. https://doi.org/10.1016/j.mayocp.2019.01.018CrossRefPubMed

Fu W, Liu Y, Xia L et al (2020) A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-kappa plus TFF2 in patients with moderate COVID-19. EClinicalMedicine 25:100478. https://doi.org/10.1016/j.eclinm.2020.100478CrossRefPubMedPubMedCentral

Hoffmann W (2005) Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 62(24):2932–2938. https://doi.org/10.1007/s00018-005-5481-9CrossRefPubMed

Huang Y, Wang MM, Yang ZZ et al (2020) Pretreatment with intestinal trefoil factor alleviates stress-induced gastric mucosal damage via Akt signaling. World J Gastroenterol 26(48):7619–7632. https://doi.org/10.3748/wjg.v26.i48.7619CrossRefPubMedPubMedCentral

Iyengar Y, Jangra R (2019) Trefoil factor 2-C-X-C chemokine receptor 4-mediated calcium signalling is implicated in gastric epithelial restitution. J Physiol 597(18):4685–4687. https://doi.org/10.1113/JP278602CrossRefPubMed

Jahan R, Shah A, Kisling SG et al (2020) Odyssey of trefoil factors in cancer: diagnostic and therapeutic implications. Biochim Biophys Acta Rev Cancer 1873(2):188362. https://doi.org/10.1016/j.bbcan.2020.188362CrossRefPubMed

Jakkawanpitak C, Hutadilok-Towatana N, Sermwittayawong D (2020) Fungal-like particles and macrophage-conditioned medium are inflammatory elicitors for 3T3-L1 adipocytes. Sci Rep 10(1):9437. https://doi.org/10.1038/s41598-020-66283-4CrossRefPubMedPubMedCentral

Kjellev S, Vestergaard EM, Nexo E et al (2007) Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents. Peptides 28(6):1197–1206. https://doi.org/10.1016/j.peptides.2007.03.016CrossRefPubMed

Liu X, Zuo D, Fan H et al (2014) Over-expression of CXCR4 on mesenchymal stem cells protect against experimental colitis via immunomodulatory functions in impaired tissue. J Mol Histol 45(2):181–193. https://doi.org/10.1007/s10735-013-9541-4CrossRefPubMed

Liu C, Yan X, Zhang Y et al (2022) Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J Nanobiotechnol 20(1):206. https://doi.org/10.1186/s12951-022-01421-wCrossRef

Lopetuso LR, De Salvo C, Pastorelli L et al (2018) IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair. Proc Natl Acad Sci USA 115(40):E9362–E9370. https://doi.org/10.1073/pnas.1803613115CrossRefPubMedPubMedCentral

Mak WY, Zhao M, Ng SC, Burisch J (2020) The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol 35(3):380–389. https://doi.org/10.1111/jgh.14872CrossRefPubMed

Na SY, Moon W (2019) Perspectives on current and novel treatments for inflammatory bowel disease. Gut Liver 13(6):604–616. https://doi.org/10.5009/gnl19019CrossRefPubMedPubMedCentral

Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329–342. https://doi.org/10.1038/nri3661CrossRefPubMed

Oertel M, Graness A, Thim L et al (2001) Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol 25(4):418–424. https://doi.org/10.1165/ajrcmb.25.4.4429CrossRefPubMed

Pagano E, Romano B, Iannotti FA et al (2019) The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients. Pharmacol Res 149:104464. https://doi.org/10.1016/j.phrs.2019.104464CrossRefPubMed

Pagano E, Iannotti FA, Piscitelli F et al (2021) Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation. Phytother Res 35(1):517–529. https://doi.org/10.1002/ptr.6831CrossRefPubMed

Pan Q, Lin S, Li Y et al (2021) A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. EBioMedicine 63:103202. https://doi.org/10.1016/j.ebiom.2020.103202CrossRefPubMedPubMedCentral

Podolsky DK, Gerken G, Eyking A, Cario E (2009) Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137(1):209–220. https://doi.org/10.1053/j.gastro.2009.03.007CrossRefPubMed

Shen X, Li Q, Wang F et al (2018) Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo. Biomed Pharmacother 108:610–617. https://doi.org/10.1016/j.biopha.2018.09.064CrossRefPubMed

Silvestri C, Pagano E, Lacroix S et al (2020) Fish oil, cannabidiol and the gut microbiota: an investigation in a murine model of colitis. Front Pharmacol 11:585096. https://doi.org/10.3389/fphar.2020.585096CrossRefPubMedPubMedCentral

Spalinger MR, Sayoc-Becerra A, Ordookhanian C et al (2021) The JAK inhibitor tofacitinib rescues intestinal barrier defects caused by disrupted epithelial-macrophage interactions. J Crohns Colitis 15(3):471–484. https://doi.org/10.1093/ecco-jcc/jjaa182CrossRefPubMed

Tran CP, Cook GA, Yeomans ND, Thim L, Giraud AS (1999) Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 44(5):636–642. https://doi.org/10.1136/gut.44.5.636CrossRefPubMedPubMedCentral

Wang W, Zhang D, Yang R et al (2018) Hepatic and cardiac beneficial effects of a long-acting Fc-apelin fusion protein in diet-induced obese mice. Diabetes Metab Res Rev 34(5):e2997. https://doi.org/10.1002/dmrr.2997CrossRefPubMed

Wang F, Cui Y, Shen X, Wang S, Yang GB (2019) IL-17A and IL-17F repair HIV-1 gp140 damaged Caco-2 cell barriers by upregulating tight junction genes. Microbes Infect 21(8–9):393–400. https://doi.org/10.1016/j.micinf.2019.03.003CrossRefPubMed

Wong WM, Poulsom R, Wright NA (1999) Trefoil peptides. Gut 44(6):890–895. https://doi.org/10.1136/gut.44.6.890CrossRefPubMedPubMedCentral

Wu MM, Wang QM, Huang BY et al (2021) Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacol Res 172:105796. https://doi.org/10.1016/j.phrs.2021.105796CrossRefPubMed

Xi Y, Yu D, Yang R et al (2019) Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats. Int J Cardiol 292:180–187. https://doi.org/10.1016/j.ijcard.2019.04.089CrossRefPubMed

Xu Z, Chen W, Deng Q et al (2020) Flaxseed oligosaccharides alleviate DSS-induced colitis through modulation of gut microbiota and repair of the intestinal barrier in mice. Food Funct 11(9):8077–8088. https://doi.org/10.1039/d0fo01105cCrossRefPubMed

Zhao S, Wan X, Dai Y, Gong L, Le Q (2022) WNT16B enhances the proliferation and self-renewal of limbal epithelial cells via CXCR4/MEK/ERK signaling. Stem Cell Reports 17(4):864–878. https://doi.org/10.1016/j.stemcr.2022.03.001CrossRefPubMedPubMedCentral

Zhou F, Mei J, Han X et al (2019) Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-kappaB/MAPK signaling and protecting chondrocytes. Acta Pharm Sin B 9(5):973–985. https://doi.org/10.1016/j.apsb.2019.01.015CrossRefPubMedPubMedCentral

Zimmerman NP, Vongsa RA, Faherty SL, Salzman NH, Dwinell MB (2011) Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution. Lab Invest 91(7):1040–1055. https://doi.org/10.1038/labinvest.2011.77CrossRefPubMedPubMedCentral

Titel: Human TFF2-Fc fusion protein alleviates DSS-induced ulcerative colitis in C57BL/6 mice by promoting intestinal epithelial cells repair and inhibiting macrophage inflammation
verfasst von: Meng Guo
Rongrong Wang
Jiajia Geng
Zhen Li
Mingfei Liu
Xuxiu Lu
Jianteng Wei
Ming Liu
Publikationsdatum: 02.05.2023
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 3/2023
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-023-01226-9

Review of natural compounds for potential psoriasis treatment

Open Access
Review

Biseugenol from Ocotea cymbarum (Lauraceae) attenuates inflammation, angiogenesis and collagen deposition of sponge-induced fibrovascular tissue in mice

Original Article

Pterostilbene reduces the progression of atopic dermatitis via modulating inflammatory and oxidative stress biomarkers in mice

Original Article

Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

Review

Microglia polarization in nociplastic pain: mechanisms and perspectives

Open Access
Review

Potential effects of carbon monoxide donor and its nanoparticles on experimentally induced gastric ulcer in rats

Open Access
Original Article

Springer Medizin

Human TFF2-Fc fusion protein alleviates DSS-induced ulcerative colitis in C57BL/6 mice by promoting intestinal epithelial cells repair and inhibiting macrophage inflammation

Abstract

Weitere Artikel der Ausgabe 3/2023

Review of natural compounds for potential psoriasis treatment

Biseugenol from Ocotea cymbarum (Lauraceae) attenuates inflammation, angiogenesis and collagen deposition of sponge-induced fibrovascular tissue in mice

Pterostilbene reduces the progression of atopic dermatitis via modulating inflammatory and oxidative stress biomarkers in mice

Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

Microglia polarization in nociplastic pain: mechanisms and perspectives

Potential effects of carbon monoxide donor and its nanoparticles on experimentally induced gastric ulcer in rats

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Review of natural compounds for potential psoriasis treatment

Biseugenol from Ocotea cymbarum (Lauraceae) attenuates inflammation, angiogenesis and collagen deposition of sponge-induced fibrovascular tissue in mice

Pterostilbene reduces the progression of atopic dermatitis via modulating inflammatory and oxidative stress biomarkers in mice

Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

Microglia polarization in nociplastic pain: mechanisms and perspectives

Potential effects of carbon monoxide donor and its nanoparticles on experimentally induced gastric ulcer in rats